EqualOcean uses cookies to improve functionality and performance of this site. More information could be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

Yusuf I. Tuna

Yusuf I. Tuna

Yusuf I. Tuna is covering healthcare, big data and machine learning related growth-stage Chinese companies. He is experienced in China's IT industry, and from an economics background.

EqualOcean Presents: The 30 Foreign Entrepreneurs in China 2019
EqualOcean Presents: The 30 Foreign Entrepreneurs in China 2019
Surging demand from the growing middle class, incentives from local governments and a burgeoning business ecosystem. China has never been so attractive for foreigners to thrive their business in. EqualOcean present "The 30 Foreign Entrepreneurs in China 2019" list.
AI Dec. 8, 2019
Surging demand from the growing middle class, incentives from local governments and a burgeoning business ecosystem. China has never been so attractive for foreigners to thrive their business in. EqualOcean present "The 30 Foreign Entrepreneurs in China 2019" list.
Healthtech: Trends and Startups 2019
Healthtech: Trends and Startups 2019
Next Global Tech 50
Healthcare Dec. 7, 2019
Next Global Tech 50

MOST READ

Recruitment App Boss Zhipin Bags Series E from Tencent, Speculate Chinese Media
Recruitment App Boss Zhipin Bags Series E from Tencent, Speculate Chinese Media
Boss Zhipin – whose CEO had eyed going public at the end of this year in the US – has been said to have raised a Series E funding round from Tencent.
Software Nov. 28, 2019
Software
Meet LinkingMed, the Chinese Startup Who Wants to Redefine Radiotherapy
Meet LinkingMed, the Chinese Startup Who Wants to Redefine Radiotherapy
EqualOcean sat down with the CEO of LinkingMed to get a glimpse into his business. The following is a recap of our conversation on how the Chinese startup is striving to flourish in the oncology field with its cutting-edge technologies.
Healthcare Nov. 25, 2019
Healthcare
CICC and Vivo Capital Inject CNY 500 mn into Genetron, it Applies IPO in the US
CICC and Vivo Capital Inject CNY 500 mn into Genetron, it Applies IPO in the US
Genetron has secured over CNY 500 million from state-backed CICC's healthcare arm and healthcare-focused investment firm Vivo Capital. Just after the announcement, the firm applied for an IPO in the US to raise USD 100 more on November 21.
Healthcare Nov. 21, 2019
Healthcare
Alibaba Buys 4% of Meinian Onehealth, China's Largest Medical Checkup Provider
Alibaba Buys 4% of Meinian Onehealth, China's Largest Medical Checkup Provider
Alibaba, a conglomerate that is operating in tens of industries including healthcare, has subscribed over 4% of Meinian Onehealth's shares worth CNY 1.8 billion.
Healthcare Nov. 17, 2019
Healthcare
Biotech in China: Oasis in the Desert?
Biotech in China: Oasis in the Desert?
Following AstraZeneca's USD 1 billion-large capital injection plans with China's state-backed CICC, and I-Mab Biopharma's long-anticipated IPO, all eyes are back on China's lucrative Biotech scene. EqualOcean sums up the story.
Healthcare Nov. 12, 2019
Healthcare
Yuanxin Huibao CEO: Our Motto is "Cancer Treatment for all Chinese"
Yuanxin Huibao CEO: Our Motto is "Cancer Treatment for all Chinese"
On November 6, EqualOcean held a meeting with Peng Xuan, co-CEO of Yuanxin Huibao, getting a glimpse into his insurance firm's business. Here is how the 'insurance products for cancer' got started in China – and got successful.
Healthcare Nov. 8, 2019
Healthcare
BGI-challenger Yikon Genomics Secures over CNY 220 Million
BGI-challenger Yikon Genomics Secures over CNY 220 Million
Yikon Genomics, a Shanghai-based reproductive genetic service and cancer diagnosis provider, secured over CNY 220 million to invest in R&D for its maternal and child health-focused products.
Healthcare Nov. 5, 2019
Healthcare
LinkingMed Lures Venture Capitalists after "Class III" License
LinkingMed Lures Venture Capitalists after "Class III" License
Th radiotherapy-support-focused AI company secured over CNY 40 million in its Series A+ funding round to bankroll its ‘costly’ product registration process in China.
Healthcare Oct. 31, 2019
Healthcare
OnQuality Secures First Funding to lead China's 'Supportive Cancer Care' Scene
Oct. 29, 2019
OnQuality Secures First Funding to lead China's 'Supportive Cancer Care' Scene
Oncodermatology focused novel drug developer OnQuality has announced its first round of financing which it claims will bankroll its Phase II clinical trials in the US.
Oct. 29, 2019
Healthcare

OnQuality Secures First Funding to lead China's 'Supportive Cancer Care' Scene

by Yusuf I. Tuna Oct. 29, 2019
GGV Taps China’s Evolving Drug Delivery Scene with Foray into SaaS
Oct. 23, 2019
GGV Taps China’s Evolving Drug Delivery Scene with Foray into SaaS
California-based GGV Capital, famous for its early-stage investments in Alibaba and Xiaomi, has reinvested in a Beijing-based enterprise SaaS company that facilitates drug distribution for pharmacies.
Oct. 23, 2019
Healthcare

GGV Taps China’s Evolving Drug Delivery Scene with Foray into SaaS

by Yusuf I. Tuna Oct. 23, 2019
'The Great Globalization Forward' Continues in CRO Scene: dMed Secures New Round
Oct. 19, 2019
'The Great Globalization Forward' Continues in CRO Scene: dMed Secures New Round
Qiming-backed dMed Biopharma undertook its Series B funding round worth USD 55 million led by Vivo Capital. The transaction represented yet another funding in China's rising CRO industry stemming from the newly-drafted NMPA policies.
Oct. 19, 2019
Healthcare

'The Great Globalization Forward' Continues in CRO Scene: dMed Secures New Round

by Yusuf I. Tuna Oct. 19, 2019
These Foreign Firms Have Bet Big on China after 40 years of Opening Up
Oct. 15, 2019
These Foreign Firms Have Bet Big on China after 40 years of Opening Up
China has always been attractive for the foreign merchants, yet the country was never easy to enter. EO Intelligence publishes the ranking of the 150 publicly traded international companies who penetrated furthest into the Chinese market.
Oct. 15, 2019
AI

These Foreign Firms Have Bet Big on China after 40 years of Opening Up

by Yusuf I. Tuna Oct. 15, 2019
Pinduoduo's Latecomer Online Pharmacy Unit Bets on Medical Devices
Oct. 7, 2019
Pinduoduo's Latecomer Online Pharmacy Unit Bets on Medical Devices
Pinduoduo, a formidable contender for Alibaba and JD.com in the mainland, has accumulated serious traffic on its 'online pharmacy' unit and cemented its healthcare category by the promotion of affordable medical devices.
Oct. 7, 2019
Healthcare

Pinduoduo's Latecomer Online Pharmacy Unit Bets on Medical Devices

by Yusuf I. Tuna Oct. 7, 2019
Chinese Drugmakers Gear Up in R&D to Develop Lucrative Novel Drugs
Oct. 4, 2019
Chinese Drugmakers Gear Up in R&D to Develop Lucrative Novel Drugs
Since the introduction of new national drug policy, China's largest pharmaceutical companies have been increasing their efforts in R&D to produce ‘Made in China’ novel drugs.
Oct. 4, 2019
Healthcare

Chinese Drugmakers Gear Up in R&D to Develop Lucrative Novel Drugs

by Yusuf I. Tuna Oct. 4, 2019
BGI Reinvests in an NGS Services Startup Geneplus
Oct. 2, 2019
BGI Reinvests in an NGS Services Startup Geneplus
Geneplus has carried out its Series B funding round led by Co-Stone Asset Management and its former investors, including BGI Genomics.
Oct. 2, 2019
Healthcare

BGI Reinvests in an NGS Services Startup Geneplus

by Yusuf I. Tuna Oct. 2, 2019
China's Xiidra Challenger VivaVision Biopharma Carries Out Series C
Sep. 28, 2019
China's Xiidra Challenger VivaVision Biopharma Carries Out Series C
VivaVision Biopharma undertook its Series C funding round, hoping to create a blockbuster drug for the treatment of ‘dry eye syndrome.’
Sep. 28, 2019
Healthcare

China's Xiidra Challenger VivaVision Biopharma Carries Out Series C

by Yusuf I. Tuna Sep. 28, 2019
READ MORE

EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.

We strive to make technology inclusive, accessible and transparent.

Join over 70,000 of your peers

Privacy Terms of service Copyright

Copyright ©2019 EqualOcean.com. All rights reserved.